TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
3D Medicines, Inc. ( (HK:1244) ) has issued an update.
3D Medicines Inc. has announced a significant breakthrough in its ‘AI + mRNA’ cancer vaccine strategy. The company has filed a patent for a key component in lipid nanoparticles used for nucleic acid drug delivery. This development enhances drug targeting and efficiency, addressing challenges in non-specific tissue distribution and building a competitive advantage in the market.
More about 3D Medicines, Inc.
3D Medicines Inc. is a company incorporated in the Cayman Islands, focusing on the biotechnology industry. The company specializes in the development of innovative cancer treatments, particularly through the use of mRNA technology and artificial intelligence to enhance drug delivery and targeting.
YTD Price Performance: -4.87%
Average Trading Volume: 444,657
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$756.5M
For an in-depth examination of 1244 stock, go to TipRanks’ Stock Analysis page.